Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippa Easterbrook

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Diagnostics (Basel, Switzerland)|March 6, 2021
Acceptability and Usability of HCV Self-Testing in High Risk Populations in VietnamLinh Thuy Nguyen, Van Thi Thuy Nguyen, Kim Anh Le Ai, et al.
The Lancet. Gastroenterology & Hepatology|August 17, 2025
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysisAlexander J Stockdale, Bethany Holt, Ajeet Singh Bhadoria, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3Kholoud Porter, Sarah Walker, Teresa Hill, et al.
International Journal of STD & AIDS|August 18, 2017
Significant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe-Africa Research Network for the Evaluation of Second-line Therapy trialJane N Wanyama, Maria S Nabaggala, Bonnie Wandera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Characterization of CD4(+) CTLs ex vivoVictor Appay, John J Zaunders, Laura Papagno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm studySonjelle Shilton, Jessica Markby, Maia Japaridze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infectionGeraldine M A Gillespie, Guillaume Stewart-Jones, Jaya Rengasamy, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2026
Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysisDaniela Yucuma, Arthur Rakover, Zakary Ismail Warsop, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2022
Expanding community engagement and advocacy in chronic viral hepatitisEneyi E Kpokiri, Dalia Elasi, Tiange P Zhang, et al.
The Journal of Infectious Diseases|July 29, 2009
Virological response to initial antiretroviral regimens containing abacavir or tenofovirLoveleen Bansi, Caroline Sabin, Richard Gilson, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Diagnostics (Basel, Switzerland)|March 6, 2021
Acceptability and Usability of HCV Self-Testing in High Risk Populations in VietnamLinh Thuy Nguyen, Van Thi Thuy Nguyen, Kim Anh Le Ai, et al.
The Lancet. Gastroenterology & Hepatology|August 17, 2025
Service delivery models and care cascade outcomes for people living with chronic hepatitis B: a global systematic review and meta-analysisAlexander J Stockdale, Bethany Holt, Ajeet Singh Bhadoria, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3Kholoud Porter, Sarah Walker, Teresa Hill, et al.
International Journal of STD & AIDS|August 18, 2017
Significant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe-Africa Research Network for the Evaluation of Second-line Therapy trialJane N Wanyama, Maria S Nabaggala, Bonnie Wandera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
Characterization of CD4(+) CTLs ex vivoVictor Appay, John J Zaunders, Laura Papagno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 7, 2022
Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm studySonjelle Shilton, Jessica Markby, Maia Japaridze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infectionGeraldine M A Gillespie, Guillaume Stewart-Jones, Jaya Rengasamy, et al.
The Lancet. Gastroenterology & Hepatology|March 16, 2026
Natural history of chronic hepatitis B in untreated adults without cirrhosis according to baseline hepatitis B virus DNA and alanine aminotransferase concentrations: a systematic review and meta-analysisDaniela Yucuma, Arthur Rakover, Zakary Ismail Warsop, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2022
Expanding community engagement and advocacy in chronic viral hepatitisEneyi E Kpokiri, Dalia Elasi, Tiange P Zhang, et al.
The Journal of Infectious Diseases|July 29, 2009
Virological response to initial antiretroviral regimens containing abacavir or tenofovirLoveleen Bansi, Caroline Sabin, Richard Gilson, et al.
Pageof 15